Fortress Biotech/FBIO

$1.96

5.95%
-
1D1W1MYTD1YMAX

About Fortress Biotech

Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an oral capsule for the treatment of severe recalcitrant nodular acne. Amzeeq (minocycline 4%) topical foam is a topical minocycline treatment for the inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and children nine years and older. Zilxi (minocycline 1.5%) is a topical foam and a topical minocycline treatment for inflammatory lesions of rosacea in adults. Ximino (minocycline hydrochloride) is an oral minocycline drug for the treatment of moderate to severe acne.

Ticker

FBIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Lindsay Rosenwald

Employees

187

Headquarters

Bay harbor islands, United States

Fortress Biotech Metrics

BasicAdvanced
$31.98M
Market cap
-
P/E ratio
-$12.29
EPS
1.47
Beta
-
Dividend rate

What the Analysts think about Fortress Biotech

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
1,940.82% upside
High $75.00
Low $10.00
$1.96
Current price
$40.00
Average price target

Fortress Biotech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-14.4% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$34.7M
100.58%
Net income
$-5M
-79.76%
Profit margin
-14.4%
-89.91%

Fortress Biotech Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 70.68%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$4.46
-$3.15
-$3.60
-$0.94
-
Expected
-$3.38
-$3.00
-$3.41
-$3.21
-$2.35
Surprise
32.16%
5%
5.49%
-70.68%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Fortress Biotech stock

Buy or sell Fortress Biotech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing